Clinical Trials Directory

Trials / Completed

CompletedNCT00890214

Prostacyclin's Effect on Platelet Responsiveness

Heparin Versus Prostacyclin in Continuous Hemodiafiltration for Acute Renal Failure: Effects on Platelet Responsiveness in the Systemic Circulation and Across the Filter.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Catholic University of the Sacred Heart · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The researchers investigated the influence of a prostacyclin analogue (PGIA) versus unfractionated heparin (UFH) on ex vivo platelet function, during continuous venovenous hemodiafiltration.

Detailed description

Context and purpose of the study: Prospective, randomized comparison of a PGIA versus UFH as circuit anticoagulant. Platelet responsiveness was assessed from peripheral blood by light-transmittance aggregometry (LTA) induced by collagen and ADP, at baseline, 4 and 24 hrs after treatment onset. Platelet function was also assessed in blood samples collected in the circuit before and after the filter. The Setting was a University Hospital Intensive Care Unit. 23 ICU patients with Acute Renal Failure needing CVVHDF were studied during standard CVVHDF therapy, at random infusion in the extracorporeal circuit of PGIA or UFH.

Conditions

Interventions

TypeNameDescription
DRUGprostacyclinprostacyclin was infused as CRRT circuit anticoagulant into the arterial-line of the circuit at 4 ng/Kg/min
DRUGheparinwas prepared using our standard protocol: 2 ml of an already-stored solution containing 5000 IU/ml of UFH were diluted in 20 ml of saline obtaining a final concentration of 500 IU/ml, and infused pre-filter at 6 IU/Kg/h, according to the post-filter activated clotting time measured hourly, and adjusted to obtain a value between 180 and 200 sec.

Timeline

Start date
2007-09-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2009-04-29
Last updated
2009-04-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00890214. Inclusion in this directory is not an endorsement.